GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CBD Life Sciences Inc (OTCPK:CBDL) » Definitions » Buyback Yield %

CBD Life Sciences (CBD Life Sciences) Buyback Yield % : 0.00 (As of May. 26, 2024)


View and export this data going back to 2009. Start your Free Trial

What is CBD Life Sciences Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

CBD Life Sciences's current buyback yield was 0.00%.


CBD Life Sciences Buyback Yield % Historical Data

The historical data trend for CBD Life Sciences's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CBD Life Sciences Buyback Yield % Chart

CBD Life Sciences Annual Data
Trend Dec11 Dec12 Dec13 Dec14
Buyback Yield %
- - - -

CBD Life Sciences Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CBD Life Sciences's Buyback Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, CBD Life Sciences's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CBD Life Sciences's Buyback Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CBD Life Sciences's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where CBD Life Sciences's Buyback Yield % falls into.



CBD Life Sciences Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

CBD Life Sciences's Buyback Yield for the fiscal year that ended in Dec. 2014 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0.685 + 0) /
=N/A%

CBD Life Sciences's annualized Buyback Yield for the quarter that ended in Sep. 2015 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (0 + 0) * 4 /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Sep. 2015) data.


CBD Life Sciences Buyback Yield % Related Terms

Thank you for viewing the detailed overview of CBD Life Sciences's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


CBD Life Sciences (CBD Life Sciences) Business Description

Traded in Other Exchanges
N/A
Address
10853 N. Frank Llyod Wright Boulevard, Suite 108, Scottsdale, AZ, USA, 85259
CBD Life Sciences Inc is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products. The company is also in the process of developing an anti-aging skin product line.